This study found an improvement in the RSR of patients with ccRCC during 2001-2020. Understanding the change trend of the survival rate of patients with ccRCC is helpful to improve the design of clinical trials. It also provides basic data and a scientific basis for evaluating the harm of ccRCC on the health of affected patients and the effect of cancer prevention, and developing cancer prevention plans.
Keyphrases
- clinical trial
- papillary thyroid
- end stage renal disease
- healthcare
- public health
- squamous cell
- ejection fraction
- newly diagnosed
- mental health
- randomized controlled trial
- prognostic factors
- squamous cell carcinoma
- electronic health record
- peritoneal dialysis
- health insurance
- childhood cancer
- patient reported outcomes
- patient reported
- phase ii